Colorado Community Engagement Alliance
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT07440316
- Status
- Recruiting
Conditions
- Diabetes
- Hypertension
- Mental Health
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 90 Years
- Healthy Volunteers
- Accepted
Interventions
- Individual awareness and focused behavior change — BEHAVIORALTranscreation of existing or new behavioral/knowledge-focused intervention.
Study Details
The Colorado Community Engagement Alliance (CO-CEAL) is a partnership between the University of Colorado Anschutz Medical Campus, several community-based organizations, and dozens of trusted local community members. Its mission is to address disproportionate impacts on health through active community engagement and outreach, capacity building, and long-lasting community partnerships to improve participation in health research. Funding for CEAL comes from the National Institutes of Health (NIH).
Key Dates
- Start date
- Nov 23, 2025
- Status verified
- Feb 2026
- Primary completion
- Jun 30, 2027
- Completion
- Jun 30, 2027
Study Design
- Enrollment
- 1,500 participants (estimated)
Arms
- Arm: Urban Latina/o/xUrban Latina/o/x in Metro Denver and Pueblo
- Arm: Rural Latina/o/xRural Latina/o/x in the San Luis Valley
- Arm: Urban Black/African AmericanUrban Black/African American in Metro Denver
- Arm: Rural East AfricanRural East African immigrant in Fort Morgan and Greeley
- Arm: American Indian/Alaska NativeAmerican Indian/Alaska Native in Metro Denver and Boulder
Primary Outcome Measure
Change in the number of respondents reporting how many times per week over the past month do they eat a green leafy or lettuce salad, with or without other vegetables as measured by Common Survey 4. [ Time Frame: From Baseline Common Survey 4 to Follow-Up Common Survey 4, up to 2 years ]
Central Contacts
- Donald Nease, Jr., MD303.724.7283
- Montelle Tamez
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Colorado - Anschutz Medical Campus | Aurora | Colorado | 80045 | Montelle Tamez Donald Nease, Jr., MD (PRINCIPAL_INVESTIGATOR) Ricardo Gonzalez-Fisher, MD, MPH, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Aurora, CO
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Nicotinamide Riboside for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older AdultsPHASE2 · Recruiting · Douglas Seals · Boulder, Colorado
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose IntolerancePHASE2 · Recruiting · University of Pennsylvania · Aurora, Colorado